tiprankstipranks
Trending News
More News >
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
Advertisement

Ovid Therapeutics (OVID) Similar Stocks

Compare
1,616 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ovid Therapeutics
$1.49
$105.95M
-2.77
27.35%
8 Buy
0 Hold
0 Sell
Strong Buy
Opus Genetics
$1.93
$115.62M
-1.10
42.96%
5 Buy
0 Hold
0 Sell
Strong Buy
Zentalis Pharmaceuticals
$1.71
$107.48M
-36.67%
4 Buy
4 Hold
0 Sell
Moderate Buy
Inhibikase Therapeutics
$1.47
$114.76M
-1.42
-44.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Surrozen
$13.73
$117.84M
-0.99
41.56%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biomea Fusion
$1.38
$106.76M
-88.56%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OVID
Ovid Therapeutics
1.49
0.36
31.86%
IRD
Opus Genetics
1.93
0.73
60.83%
ZNTL
Zentalis Pharmaceuticals
1.71
-1.02
-37.36%
IKT
Inhibikase Therapeutics
1.47
-1.06
-41.90%
SRZN
Surrozen
13.73
0.29
2.16%
BMEA
Biomea Fusion
1.38
-7.99
-85.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis